Back to Search Start Over

Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.

Authors :
Sherborne AL
Hosking FJ
Prasad RB
Kumar R
Koehler R
Vijayakrishnan J
Papaemmanuil E
Bartram CR
Stanulla M
Schrappe M
Gast A
Dobbins SE
Ma Y
Sheridan E
Taylor M
Kinsey SE
Lightfoot T
Roman E
Irving JA
Allan JM
Moorman AV
Harrison CJ
Tomlinson IP
Richards S
Zimmermann M
Szalai C
Semsei AF
Erdelyi DJ
Krajinovic M
Sinnett D
Healy J
Gonzalez Neira A
Kawamata N
Ogawa S
Koeffler HP
Hemminki K
Greaves M
Houlston RS
Source :
Nature genetics [Nat Genet] 2010 Jun; Vol. 42 (6), pp. 492-4. Date of Electronic Publication: 2010 May 09.
Publication Year :
2010

Abstract

Using data from a genome-wide association study of 907 individuals with childhood acute lymphoblastic leukemia (cases) and 2,398 controls and with validation in samples totaling 2,386 cases and 2,419 controls, we have shown that common variation at 9p21.3 (rs3731217, intron 1 of CDKN2A) influences acute lymphoblastic leukemia risk (odds ratio = 0.71, P = 3.01 x 10(-11)), irrespective of cell lineage.

Details

Language :
English
ISSN :
1546-1718
Volume :
42
Issue :
6
Database :
MEDLINE
Journal :
Nature genetics
Publication Type :
Academic Journal
Accession number :
20453839
Full Text :
https://doi.org/10.1038/ng.585